Search

2645 Results

Last update: : 12.02.2025

Our Research The D3lab emerged from the DKFZ-Bayer Immunotherapeutics laboratory that over the past 10 years served as the hub for immuno-oncology (I.O.) drug development in the context of the…

Last update: : 12.02.2025

Our Research Our research group investigates various possibilities for optimizing T cell-mediated tumor defense and prepares their application together with clinical cooperation partners. In our…

Last update: : 12.02.2025

The Topics missions are twofold: To understand immune reactivity to and develop effective immunotherapies for cancer through single-cell analyses and targeted manipulation of immune cells from…

Last update: : 12.02.2025

Theresa Schindler +49 6221 42 4970 D430 Administration

Last update: : 12.02.2025

Integrating recent advances in the fields of genetic and molecular biology, digital oncology and imaging will further boost progress in cancer prevention.  Our research topic The…

Last update: : 12.02.2025

GERMAN CANCER AID AND DKFZ – OCTOBER 2023 Memorandum on cancer prevention research in Germany With support from German Cancer Aid (Deutsche Krebshilfe) was founded on September 25, 1974 by Dr…

Document

Last update: : 12.02.2025

We develop and operate national IT infrastructures for the secure exchange of patient data, for example between the university hospitals in the German Consortium for Translational Cancer…

PIP_FAQ_2025.pdf PDF, 556.89 KB

Last update: : 11.02.2025

DKFZ Postdoc Internship Program (PIP) / FAQs (Frequently Asked Questions) Tuesday, 11 February 2025 DKFZ Postdoc Internship Program (PIP) 1 January 2025 - 30 March 2025 FAQs (Frequently Asked…

Document

Last update: : 11.02.2025

Team GMP & T cell therapy head of research group Prof. Dr. Stefan Eichmüller research unit  Dr. Wolfram Osen, group leader preclinical research Felix Andres, PhD Student  Elke…

Last update: : 11.02.2025

Carla Siebenkotten +49 6221 42 4975 D430

Form

Form data is loaded ...